4 October 2020 - Price controls would deny researchers funds for next generation of cures.
President Trump recently issued a blitz of executive orders in an attempt to fulfill his promise to reduce drug prices.
One of those orders would put in place a “cure” far worse than the disease. The order in question establishes foreign reference pricing, whereby the federal government ties its reimbursement rates for certain drugs dispensed under Medicare Part B and Part D to the lower prices available in countries with per-capita GDP comparable to that of the United States. Germany is one of those countries.